On March 19, 2022, Sichuan Walvax Innovation Biotechnology Co., Ltd closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.12 CNY | +0.20% | +2.79% | -35.69% |
Apr. 26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.69% | 3.34B | |
-3.59% | 89.33B | |
+4.08% | 41.19B | |
-15.09% | 31.87B | |
+53.68% | 24.52B | |
-15.13% | 15.68B | |
-8.63% | 12.34B | |
-40.39% | 12.23B | |
+6.22% | 8.83B | |
-6.20% | 8.28B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Sichuan Walvax Innovation Biotechnology Co., Ltd announced that it has received CNY 150 million in funding from Walvax Biotechnology Co., Ltd.